HCA Healthcare Statistics
Total Valuation
HCA Healthcare has a market cap or net worth of $110.68 billion. The enterprise value is $159.29 billion.
Important Dates
The next estimated earnings date is Friday, April 24, 2026, before market open.
| Earnings Date | Apr 24, 2026 |
| Ex-Dividend Date | Mar 17, 2026 |
Share Statistics
HCA Healthcare has 223.62 million shares outstanding. The number of shares has decreased by -8.52% in one year.
| Current Share Class | 223.57M |
| Shares Outstanding | 223.62M |
| Shares Change (YoY) | -8.52% |
| Shares Change (QoQ) | -2.32% |
| Owned by Insiders (%) | 1.51% |
| Owned by Institutions (%) | 62.90% |
| Float | 151.16M |
Valuation Ratios
The trailing PE ratio is 17.64 and the forward PE ratio is 16.48. HCA Healthcare's PEG ratio is 1.49.
| PE Ratio | 17.64 |
| Forward PE | 16.48 |
| PS Ratio | 1.48 |
| Forward PS | 1.40 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 14.53 |
| P/OCF Ratio | 8.84 |
| PEG Ratio | 1.49 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 10.28, with an EV/FCF ratio of 20.71.
| EV / Earnings | 23.48 |
| EV / Sales | 2.11 |
| EV / EBITDA | 10.28 |
| EV / EBIT | 13.31 |
| EV / FCF | 20.71 |
Financial Position
The company has a current ratio of 0.97
| Current Ratio | 0.97 |
| Quick Ratio | 0.74 |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.95 |
| Debt / FCF | 6.33 |
| Interest Coverage | 5.32 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 12.44% |
| Return on Invested Capital (ROIC) | 21.55% |
| Return on Capital Employed (ROCE) | 26.97% |
| Weighted Average Cost of Capital (WACC) | 9.21% |
| Revenue Per Employee | $236,250 |
| Profits Per Employee | $21,200 |
| Employee Count | 320,000 |
| Asset Turnover | 1.26 |
| Inventory Turnover | 26.09 |
Taxes
In the past 12 months, HCA Healthcare has paid $2.05 billion in taxes.
| Income Tax | 2.05B |
| Effective Tax Rate | 20.85% |
Stock Price Statistics
The stock price has increased by +48.05% in the last 52 weeks. The beta is 1.34, so HCA Healthcare's price volatility has been higher than the market average.
| Beta (5Y) | 1.34 |
| 52-Week Price Change | +48.05% |
| 50-Day Moving Average | 508.97 |
| 200-Day Moving Average | 443.17 |
| Relative Strength Index (RSI) | 35.67 |
| Average Volume (20 Days) | 1,099,349 |
Short Selling Information
The latest short interest is 3.54 million, so 1.58% of the outstanding shares have been sold short.
| Short Interest | 3.54M |
| Short Previous Month | 4.14M |
| Short % of Shares Out | 1.58% |
| Short % of Float | 2.34% |
| Short Ratio (days to cover) | 2.78 |
Income Statement
In the last 12 months, HCA Healthcare had revenue of $75.60 billion and earned $6.78 billion in profits. Earnings per share was $28.33.
| Revenue | 75.60B |
| Gross Profit | 31.37B |
| Operating Income | 11.97B |
| Pretax Income | 9.83B |
| Net Income | 6.78B |
| EBITDA | 15.49B |
| EBIT | 11.97B |
| Earnings Per Share (EPS) | $28.33 |
Full Income StatementBalance Sheet
The company has $1.14 billion in cash and $48.70 billion in debt, with a net cash position of -$47.55 billion or -$212.65 per share.
| Cash & Cash Equivalents | 1.14B |
| Total Debt | 48.70B |
| Net Cash | -47.55B |
| Net Cash Per Share | -$212.65 |
| Equity (Book Value) | -2.77B |
| Book Value Per Share | -26.83 |
| Working Capital | -567.00M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $12.64 billion and capital expenditures -$4.94 billion, giving a free cash flow of $7.69 billion.
| Operating Cash Flow | 12.64B |
| Capital Expenditures | -4.94B |
| Depreciation & Amortization | 3.52B |
| Net Borrowing | 3.29B |
| Free Cash Flow | 7.69B |
| FCF Per Share | $34.40 |
Full Cash Flow StatementMargins
Gross margin is 41.50%, with operating and profit margins of 15.83% and 8.97%.
| Gross Margin | 41.50% |
| Operating Margin | 15.83% |
| Pretax Margin | 13.01% |
| Profit Margin | 8.97% |
| EBITDA Margin | 20.49% |
| EBIT Margin | 15.83% |
| FCF Margin | 10.17% |
Dividends & Yields
This stock pays an annual dividend of $3.12, which amounts to a dividend yield of 0.63%.
| Dividend Per Share | $3.12 |
| Dividend Yield | 0.63% |
| Dividend Growth (YoY) | 8.89% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 10.38% |
| Buyback Yield | 8.52% |
| Shareholder Yield | 9.15% |
| Earnings Yield | 6.07% |
| FCF Yield | 6.88% |
Dividend DetailsAnalyst Forecast
The average price target for HCA Healthcare is $528.00, which is 6.68% higher than the current price. The consensus rating is "Buy".
| Price Target | $528.00 |
| Price Target Difference | 6.68% |
| Analyst Consensus | Buy |
| Analyst Count | 21 |
| Revenue Growth Forecast (5Y) | 5.73% |
| EPS Growth Forecast (5Y) | 12.40% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HCA Healthcare has an Altman Z-Score of 2.62 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.62 |
| Piotroski F-Score | 6 |
